FDA Adverse Event Other Summary report: N

SPRING QUATTRO SECURE MRI SURESCAN LEAD

MDR report key: 22796176 · Received August 13, 2025

Report

Report Number
MW5174447
Event Type
Other
Date Received
August 13, 2025
Date of Event
July 11, 2025
Report Date
August 1, 2025
Manufacturer
MEDTRONIC, INC.
Product Code
NVY
Report Source
Voluntary report
Reporter Location
CA, US
Reporter Occupation
UNKNOWN
Health Professional
*

Narratives

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT PRESENTED TO THE HOSPITAL DUE TO EXPERIENCING SYNCOPE. UPON EXAMINATION OF THE ELECTROGRAMS (EGMS), THERE WERE EPISODES OF NOISE OVERSENSING ON THE RIGHT VENTRICULAR (RV) LEAD. THERE WERE ALSO EPISODES OF LOSS OF RV CAPTURE, SMALL R-WAVES, LOW PACING LEAD IMPEDANCE, LOW HIGH VOLTAGE LEAD IMPEDANCE, AND EPISODES OF CROSSTALK INDICATIVE OF RV LEAD FAILURE. ADDITIONAL LEAD TESTING OR LEAD REVISION WAS RECOMMENDED. THERE WAS NO FURTHER ADVERSE CONSEQUENCE TO THE PATIENT. THIS REPORT REFLECTS INFORMATION RECEIVED BY FDA IN THE FORM OF A NOTIFICATION PER 803.22 (B)(2).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
782273 SPRING QUATTRO SECURE MRI SURESCAN LEAD PERMANENT DEFIBRILLATOR ELECTRODES NVY MEDTRONIC, INC. 6947

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown